Primary aldosteronism, caused by autonomous secretion of aldosterone by the adrenals, is estimated to account for at least 5% of hypertension cases. Hypertension explains the considerable cardiovascular morbidity caused by aldosteronism only partly, calling for specific anti-aldosterone drugs. The p
Drugs in the potassium-sparing diuretic class Drugs in this class include: Aldosterone antagonists Aldosterone antagonists Drugs that bind to
Aldosterone Antagonists, Aldosterone Antagonists And Other Potassium-Sparing For brand name drugs under review and drug reviews completed on or
Aldosterone Receptor Antagonists (ARAs) are a class of drugs that are used to inhibit the action of aldosterone, a hormone that regulates sodium
Drug Mechanism Classes Adenosine receptor agonists Aldosterone-receptor antagonists Alpha-adrenoceptor agonists (alpha-agonists) Alpha-adrenoceptor
Exciting new drugs on the horizon – Eplerenone, a selective aldosterone receptor antagonist (SARA), and for the specific aldosterone antagonist
Selective Aldosterone Antagonist ANTIHYPERTENSIVE DRUGS AFFECTING THE ANS RECEPTORS: Alpha 1 Adrenergic Antagonists zosin; Alpha 2 Adrenergic Agonist; Beta
Aldosterone is the major natural mineralocorticoid in humans and there are two major classes of medications targeting the actions of mineralocorticoids: mineralocorticoid-receptor agonists, which mimic the role of aldosterone; and mineralocorticoid-receptor antagonists, that block the action of aldosterone. Alright, but first things first.
by R Agarwal 2024 Cited by 393Effect on cofactor recruitment in absence of aldosterone in vitro Spironolactone and eplerenone: partial agonistic cofactor recruitment ; Effect on cofactor
Comments